2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine
C23H17FN6S — CID 137087576
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine
2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine (PubChem CID 137087576) has the molecular formula C23H17FN6S and a molecular weight of 428.50 g/mol. Its IUPAC name is 2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine.
Molecular Properties
| Compound Name | 2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine |
|---|---|
| PubChem CID | 137087576 |
| Molecular Formula | C23H17FN6S |
| Molecular Weight | 428.50 g/mol |
| Exact Mass | 428.12 |
| IUPAC Name | 2-[5-(2,3-dimethylimidazol-4-yl)-1H-indazol-3-yl]-4-(5-fluorothiophen-2-yl)-1H-pyrrolo[2,3-c]pyridine |
| SMILES | Cc1ncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccc(F)s6)cncc5[nH]4)c3c2)n1C |
| InChI | InChI=1S/C23H17FN6S/c1-12-26-11-20(30(12)2)13-3-4-17-15(7-13)23(29-28-17)18-8-14-16(9-25-10-19(14)27-18)21-5-6-22(24)31-21/h3-11,27H,1-2H3,(H,28,29) |
| InChIKey | ZVCPWTSWIABPOX-UHFFFAOYSA-N |
| XLogP | 5.68 |
| TPSA | 75.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.50 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137087576 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.